Premium
CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis
Author(s) -
Qiu Fen,
Li Youling,
Zhu Yunhe,
Li Gang,
Lei Feifei,
Zhang Shuang,
Luo Lei,
Zhu Jietao,
Guo Yang,
Du Boyu,
Xi Xueyan
Publication year - 2021
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/sji.13038
Subject(s) - cx3cr1 , cx3cl1 , chemokine , immunology , pathogenesis , medicine , chemokine receptor , lupus erythematosus , systemic lupus erythematosus , inflammation , antibody , disease
The inflammatory process in systemic lupus erythematosus (SLE) affects many organs including the lungs. Chemokines are suggested to play important roles in the pathogenesis of SLE with pulmonary fibrosis (PF). In the present study, our objective is to evaluate the correlation between chemokines and PF in SLE patients. Transcriptome sequencing analysis was used to find the different expressed genes between SLE patients with PF and without PF. Enzyme‐linked immunosorbent assay (ELISA) was used to detect serum levels of chemokines in SLE patients and healthy controls. Expression of CX3CR1 was measured by real‐time polymerase chain reaction (PCR) and flow cytometer. Sixteen differentially chemokine genes were found to be associated to SLE with PF. Meanwhile, the upregulation of C‐X3‐C motif chemokine receptor 1 (CX3CR1 ) and its ligand, CX3C chemokine ligand 1 (CX3CL1) were observed in SLE patients with PF than that of SLE patients without PF and healthy control. Phenotypic analysis also showed that the surface expression of CX3CR1 increased in PBMCs from SLE patients with PF. Our observations indicated that CX3CL1/CX3CR1 axis is associated with PF in SLE. CX3CR1 might be a promising predictor of SLE with PF and the interactions between CX3CL1 and CX3CR1 might provide potential candidate target for the treatment of SLE with PF.